[Pelvic MRI at 3.0 Tesla]

review OA: closed public-domain-us
View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-10

This paper discusses parameters for achieving high-quality pelvic MRI at 3.0 Tesla, addressing specific high-field imaging issues and illustrating clinical results with potential vascular and functional imaging advantages.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

High resolution MR imaging is ideal for pelvic imaging. To achieve good image quality at 3.0 Tesla MR, one may not simply import protocols used at 1.5 Tesla MR. Issues specific to 3.0 Tesla MR imaging must be considered including chemical shift, magnetic susceptibility, dielectric effect, specific absorption rates (SAR), motion artifacts and optimal echo time (TE) and repetition tome (TR) to achieve the desired tissue contrast. High quality pelvic MRI (prostate, rectum, and female pelvis) at 3.0 Tesla is possible. In addition, it offers potential advantages due to its ability to provide excellent vascular imaging and advances with functional imaging (diffusion, spectroscopy). This article discusses the parameters required to achieve quality pelvic imaging at 3.0 Tesla, the specifics of high-field MR imaging, and illustrates achievable clinical results.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma Gastrointestinal Stromal Tumors Genital Neoplasms, Female Magnetic Resonance Imaging Prostatic Neoplasms Rectal Neoplasms Adenocarcinoma Adult Aged Anus Neoplasms Anus Neoplasms Artifacts Endometrial Neoplasms Endometrial Neoplasms Endometriosis Endometriosis Female Gastrointestinal Stromal Tumors Genital Neoplasms, Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
pubmed
last seen: 2026-05-13T22:14:05.573375+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine